AlphaValue/Baader Europe Downgrades Novartis to Reduce, Lifts PT

08:31 AM EDT, 07/31/2026 (MT Newswires) -- AlphaValue/Baader Europe on Friday downgraded Swiss pharmaceutical giant Novartis (NOVN.SW) to reduce from an add rating, while increasing its price target to 134 francs from 133 francs. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)